IL6 and hepatocellular carcinoma: Beyond IL-6, reduced YTHDF2 in HCC increases m6A-modified IL-11 mRNA, exacerbating inflammation and metastasis by impairing the degradation of IL11 and SERPINE2 mRNAs (62).